The close relationship of class I HDACs and RelA/p65 was confirmed in vitro, where nuclear translocation and binding activity of RelA/p65 could be markedly diminished by treatment of pancreatic cancer cells with HDAC inhibitors. The gene discussed is RELA; the disease is familial pancreatic carcinoma.